Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Anna Sankila"'
Autor:
Juha Rantala, Olli Kallioniemi, Pekka Kohonen, Stig Nordling, Kalle Alanen, Tuomas Mirtti, Tiina Vesterinen, John Patrick Mpindi, Khalid Saeed, Mikael Lundin, Johan Lundin, Päivi Östling, Mari Björkman, Antti Rannikko, Anna Sankila, Kristiina Iljin
Publikováno v:
International Journal of Cancer. 136:2535-2545
Hormonal therapies targeting androgen receptor (AR) are effective in prostate cancer (PCa), but often the cancers progress to fatal castrate-resistant disease. Improved understanding of the cellular events during androgen deprivation would help to id
Autor:
Antti Rannikko, Anna Sankila, Johan Lundin, Olli Kallioniemi, Matej Orešič, Johannes Virtanen, Kristiina Iljin, Tuomas Mirtti, Laura Lehtinen, Tuulikki Seppänen-Laakso, Stig Nordling, Paula Vainio, Mika Hilvo
Publikováno v:
University of Helsinki
Scopus-Elsevier
Europe PubMed Central
Vainio, P, Lehtinen, L, Mirtti, T, Hilvo, M, Seppänen-Laakso, T, Virtanen, J, Sankila, A, Nordling, S, Lundin, J, Rannikko, A, Orešič, M, Kallioniemi, O & Iljin, K 2011, ' Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins ', Oncotarget, vol. 2, no. 12, pp. 1176-1190 . https://doi.org/10.18632/oncotarget.397
Oncotarget
Scopus-Elsevier
Europe PubMed Central
Vainio, P, Lehtinen, L, Mirtti, T, Hilvo, M, Seppänen-Laakso, T, Virtanen, J, Sankila, A, Nordling, S, Lundin, J, Rannikko, A, Orešič, M, Kallioniemi, O & Iljin, K 2011, ' Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins ', Oncotarget, vol. 2, no. 12, pp. 1176-1190 . https://doi.org/10.18632/oncotarget.397
Oncotarget
Paula Vainio 1 , Laura Lehtinen 1 , Tuomas Mirtti 2,3,4 , Mika Hilvo 5 , Tuulikki Seppanen-Laakso 5 , Johannes Virtanen 1 , Anna Sankila 4 , Stig Nordling 4 , Johan Lundin 3 , Antti Rannikko 6 , Matej Oresic 5 , Olli Kallioniemi 1,3 and Kristiina Ilj
Autor:
Anna Sankila, Ville Rantanen, Leif C. Andersson, Sari Jäämaa, Marikki Laiho, Mirja Ruutu, Kimmo Taari, Taija af Hällström, Karita Peltonen, Päivi Järvinen
Publikováno v:
The Prostate. 72:1060-1070
BACKGROUND Prostate and seminal vesicle are two similar hormone responsive human organs that differ dramatically in their cancer incidence. DNA damage response (DDR) is required for maintenance of genomic integrity. METHODS In this study we investiga
Autor:
Olli Kallioniemi, Sampsa Hautaniemi, Kristian Ovaska, Tuomas Mirtti, Marko Laakso, Tiina Vesterinen, Stig Nordling, Juha-Pekka Turunen, Mikael Lundin, Juho Konsti, Johan Lundin, Antti Rannikko, Olli A. Jänne, Anna Sankila, Biswajyoti Sahu
Publikováno v:
The EMBO Journal. 30:3962-3976
High androgen receptor (AR) level in primary tumour predicts increased prostate cancer-specific mortality. However, the mechanisms that regulate AR function in prostate cancer are poorly known. We report here a new paradigm for the forkhead protein F
Autor:
Jukka Melkko, Anna Sankila, Harry Kujari, Martine Vornanen, Tapio Luostarinen, Stefan Lönnberg, Ahti Anttila, Laura Kotaniemi-Talonen, Gustav Granroth, Johanna Arola, Pekka Nieminen, Timo Pietiläinen
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 19:381-387
Background: We assessed the performance and validity of cytology in the Finnish screening program by considering high-grade neoplasia and cervical cancer (CIN3+) rates as detected in the program and by reevaluating cases observed after a negative scr
Publikováno v:
European Urology. 56:260-265
Background The long-term prospective data on bacillus Calmette-Guerin (BCG) and mitomycin C (MMC) instillation therapy are limited. Objective To compare the long-term benefit of BCG and MMC maintenance therapy in patients with recurrent bladder carci
Autor:
Kimmo Taari, Tuula Ranta-Knuuttila, Anna Sankila, Ilkka Perttilä, Martti Ala-Opas, Harry Nisen
Publikováno v:
Scandinavian Journal of Urology and Nephrology. 42:29-34
To report the first results of laparoscopic radical prostatectomy (LRP) at our institution.The surgical, functional and oncological outcomes of all patients who underwent LRP at Helsinki University Central Hospital between May 2002 and May 2006 were
Autor:
Anna Sankila, Henrik Alfthan, Tanja Hakkarainen, Merja Särkioja, Martti Ala-Opas, Ulf-Håkan Stenman, Maria Rajecki, Akseli Hemminki, Erkki Rintala, Renee A. Desmond, Lotta Kangasniemi, Anna Kanerva, Mikko Tenhunen
Publikováno v:
Molecular Cancer Therapeutics. 6:742-751
Hormone refractory metastatic prostate cancer is a deadly disease that currently lacks curative treatments. Conditionally replicating adenoviruses (CRAds) are promising new agents against cancer due to their innate capability to cause oncolysis of tu
Autor:
Anna Sankila, K. Seppälä, Reijo S. Tilvis, Hannu Hyvärinen, Timo U. Kosunen, Seppo Sarna, Pentti Sipponen, Perttu Arkkila, Lea Veijola, Hilpi Rautelin
Publikováno v:
University of Helsinki
Background: All the risk factors of peptic ulcer disease are not thoroughly understood. Goals: To assess duodenal gastric metaplasia (DGM) in relation to Helicobacter pylori status and endoscopy findings with special reference to the effects of highl
Autor:
Jouko Viitanen, Kimmo Taari, Martti Ala-Opas, Teuvo L.J. Tammela, Arto J. Salonen, Anna Sankila, Seppo Lundstedt
Publikováno v:
Scandinavian journal of urology. 48(6)
Objective. The aim of the study was to compare intermittent (IAD) and continuous (CAD) androgen deprivation therapy (ADT) between locally advanced (M0) and metastatic (M1) prostate cancer, and the effect of ADT on the quality of life. Material and me